BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Qian JM. The Challenge of Inflammatory Bowel Disease Diagnosis in Asia. Inflamm Intest Dis. 2016;1:159-164. [PMID: 29922672 DOI: 10.1159/000448384] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Seo H, Lee S, So H, Kim D, Kim SO, Soh JS, Bae JH, Lee SH, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD. Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis. World J Gastroenterol 2017; 23(34): 6306-6314 [PMID: 28974897 DOI: 10.3748/wjg.v23.i34.6306] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
2 Banerjee R, Pal P, Mak JWY, Ng SC. Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol 2020;5:1076-88. [PMID: 33181087 DOI: 10.1016/S2468-1253(20)30299-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Choi YI, Park SJ, Chung JW, Kim KO, Cho JH, Kim YJ, Lee KY, Kim KG, Park DK. Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study.J Clin Med. 2020;9:3427. [PMID: 33114505 DOI: 10.3390/jcm9113427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chew D, Zhiqin W, Ibrahim N, Ali RAR. Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease. Intest Res 2018;16:509-21. [PMID: 30369231 DOI: 10.5217/ir.2018.00074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]